← Leaderboards
Charles A Specht
Duke University
$2,607,227
Attributed
$7,595,493
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $799K · FY2011–25$1M$750K$500K$250K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,595,493 · 2
By mechanism
R01$7,143,118 · 1
R21$452,375 · 1
Top collaborators
- Stuart M Levitz12 shared
- Jennifer K. Lodge10 shared
Most similar at Duke University
Same institution · by research overlap
- Joseph Heitman$44,576,851
- Stuart M Levitz$22,736,478
- Jennifer K. Lodge$14,326,240
- Kenichi Yokoyama$7,433,719
- Paul Mitaari Magwene$7,260,193
Others in their field
Top investigators on “Cytokine”
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$83,965,880
- David Heimbrook · Leidos Biomedical Research, Inc.$56,453,265
- Fulton T Crews · University Of North Carolina Chapel Hill$36,249,590
- Marianne Ward · Duke University$34,872,957
- Joren C Madsen · Massachusetts General Hospital$33,058,731
- Barton F Haynes · Duke University$29,068,807
Research focus
CytokineChitosanResponseFundingVaccinationPreclinical StudyVaccine DevelopmentPersonsMediatingMutantPre-ClinicalT-LymphocyteVaccinesCryptococcusCd4 Positive T LymphocytesInfectionVaccinatedAcquired Immunodeficiency SyndromeAids VaccinesCryptococcus NeoformansInflammatory ResponseCryptococcosisImmune ResponsePopulations At Risk
Grant awards (12)
Preclinical studies of a Cryptococcus vaccine for AIDS patients$769,284
R01 · FY2025 · AI
Preclinical studies of a Cryptococcus vaccine for AIDS patients$793,078
R01 · FY2024 · AI
Preclinical studies of a Cryptococcus vaccine for AIDS patients$793,078
R01 · FY2023 · AI
Preclinical studies of a Cryptococcus vaccine for AIDS patients$753,820
R01 · FY2022 · AI
Preclinical studies of a Cryptococcus vaccine for AIDS patients$799,003
R01 · FY2021 · AI
Preclinical studies of a Cryptococcus vaccine for AIDS patients$644,346
R01 · FY2020 · AI
Preclinical studies of a Cryptococcus vaccine for AIDS patients$644,346
R01 · FY2019 · AI
Preclinical studies of a Cryptococcus vaccine for AIDS patients$644,346
R01 · FY2018 · AI
Preclinical studies of a Cryptococcus vaccine for AIDS patients$644,346
R01 · FY2017 · AI
Preclinical studies of a Cryptococcus vaccine for AIDS patients$657,471
R01 · FY2016 · AI
Immunostimulatory properties of chitin and chitosan$205,625
R21 · FY2012 · AI
Immunostimulatory properties of chitin and chitosan$246,750
R21 · FY2011 · AI